BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 33186558)

  • 1. Elevation of JAML Promotes Diabetic Kidney Disease by Modulating Podocyte Lipid Metabolism.
    Fu Y; Sun Y; Wang M; Hou Y; Huang W; Zhou D; Wang Z; Yang S; Tang W; Zhen J; Li Y; Wang X; Liu M; Zhang Y; Wang B; Liu G; Yu X; Sun J; Zhang C; Yi F
    Cell Metab; 2020 Dec; 32(6):1052-1062.e8. PubMed ID: 33186558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Zuo F; Wang Y; Xu X; Ding R; Tang W; Sun Y; Wang X; Zhang Y; Wu J; Xie Y; Liu M; Wang Z; Yi F
    Metabolism; 2024 Jan; 150():155724. PubMed ID: 37952690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
    Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
    Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol ameliorates diabetic kidney injury by reducing lipotoxicity and modulates expression of components of the junctional adhesion molecule-like/sirtuin 1 lipid metabolism pathway.
    Gu W; Wang X; Zhao H; Geng J; Li X; Zheng K; Guan Y; Hou X; Wang C; Song G
    Eur J Pharmacol; 2022 Mar; 918():174776. PubMed ID: 35090936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Exacerbates Podocyte Injury and the Progression of Diabetic Kidney Disease.
    Qu H; Gong X; Liu X; Zhang R; Wang Y; Huang B; Zhang L; Zheng H; Zheng Y
    Diabetes; 2021 Jun; 70(6):1372-1387. PubMed ID: 33741719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK/STAT pathway promotes the progression of diabetic kidney disease via autophagy in podocytes.
    Chen D; Liu Y; Chen J; Lin H; Guo H; Wu Y; Xu Y; Zhou Y; Zhou W; Lu R; Zhou J; Wu J
    Eur J Pharmacol; 2021 Jul; 902():174121. PubMed ID: 33901462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Metabolism Gets in a JAML during Kidney Disease.
    Fornoni A; Merscher S
    Cell Metab; 2020 Dec; 32(6):903-905. PubMed ID: 33264600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of podocyte autophagy in the progression of diabetic nephropathy.
    Yasuda-Yamahara M; Kume S; Tagawa A; Maegawa H; Uzu T
    Autophagy; 2015; 11(12):2385-6. PubMed ID: 26565953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte-Specific Loss of Krüppel-Like Factor 6 Increases Mitochondrial Injury in Diabetic Kidney Disease.
    Horne SJ; Vasquez JM; Guo Y; Ly V; Piret SE; Leonardo AR; Ling J; Revelo MP; Bogenhagen D; Yang VW; He JC; Mallipattu SK
    Diabetes; 2018 Nov; 67(11):2420-2433. PubMed ID: 30115650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyro3 is a podocyte protective factor in glomerular disease.
    Zhong F; Chen Z; Zhang L; Xie Y; Nair V; Ju W; Kretzler M; Nelson RG; Li Z; Chen H; Wang Y; Zhang A; Lee K; Liu Z; He JC
    JCI Insight; 2018 Nov; 3(22):. PubMed ID: 30429374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility.
    Qi H; Casalena G; Shi S; Yu L; Ebefors K; Sun Y; Zhang W; D'Agati V; Schlondorff D; Haraldsson B; Böttinger E; Daehn I
    Diabetes; 2017 Mar; 66(3):763-778. PubMed ID: 27899487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A NOX4/TRPC6 Pathway in Podocyte Calcium Regulation and Renal Damage in Diabetic Kidney Disease.
    Ilatovskaya DV; Blass G; Palygin O; Levchenko V; Pavlov TS; Grzybowski MN; Winsor K; Shuyskiy LS; Geurts AM; Cowley AW; Birnbaumer L; Staruschenko A
    J Am Soc Nephrol; 2018 Jul; 29(7):1917-1927. PubMed ID: 29793963
    [No Abstract]   [Full Text] [Related]  

  • 15. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 16. GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK/EGR1 pathway.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Int J Biol Sci; 2022; 18(1):96-111. PubMed ID: 34975320
    [No Abstract]   [Full Text] [Related]  

  • 17. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
    Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CPT1A Protects Podocytes From Lipotoxicity and Apoptosis In Vitro and Alleviates Diabetic Nephropathy In Vivo.
    Xie Y; Yuan Q; Tang B; Xie Y; Cao Y; Qiu Y; Zeng J; Wang Z; Su H; Zhang C
    Diabetes; 2024 Jun; 73(6):879-895. PubMed ID: 38506804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease.
    Li SY; Huang PH; Tarng DC; Lin TP; Yang WC; Chang YH; Yang AH; Lin CC; Yang MH; Chen JW; Schmid-Schönbein GW; Chien S; Chu PH; Lin SJ
    J Am Soc Nephrol; 2015 Dec; 26(12):3072-84. PubMed ID: 25855776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. STIM promotes the epithelial-mesenchymal transition of podocytes through regulation of FcγRII activity in diabetic nephropathy.
    Jin J; Ye M; Hu K; Gong J; He Q
    Histol Histopathol; 2019 Jun; 34(6):671-682. PubMed ID: 30475382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.